SKUYF yields 4.96% · JNJ yields 2.13%● Live data
📍 SKUYF pulled ahead of the other in Year 1
Combined, SKUYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKUYF + JNJ for your $10,000?
Sansei Technologies, Inc. plans, designs, manufactures, installs, repairs, and maintains amusement rides, stage equipment, elevators, and other designed equipment in Japan and internationally. The company's amusement rides include dark rides, mini-roller coasters, family rides and others, carousel type rides, jet-roller coasters, and flume rides. It also provides stage equipment, such as floor mechanisms comprising elevators for stage traps, sliding stages and stage wagons, inclined floors, circular-type stages, etc. In addition, the company offers rigging systems for raising and lowering the scenery, lighting, sound and screen equipment, stage curtains, acoustic panels, etc.; acoustic equipment; control systems; and stage equipment for small halls, adaptable stages, event halls, sports halls, and studios. Further, it provides property management and logistics services; operates and manages amusement facilities; and rents electric and mechanical equipment for TV programs, concerts, stages, events, etc. The company was formerly known as Sansei Yusoki Co., Ltd. and changed its name to Sansei Technologies, Inc. in January 2014. Sansei Technologies, Inc. was incorporated in 1951 and is headquartered in Osaka, Japan.
Full SKUYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.